Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles
Bruna dos Santos Rodrigues, Takahisa Kanekiyo, Jagdish Singh
Pharmaceutical Research (2019) Vol. 36, Iss. 11
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

APOE and Alzheimer’s Disease: From Lipid Transport to Physiopathology and Therapeutics
Mohammed Amir Husain, Benoît Laurent, Mélanie Plourde
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 221
Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseases
Xue Zhou, Quentin R. Smith, Xinli Liu
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2021) Vol. 13, Iss. 4
Closed Access | Times Cited: 131
Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood–Brain Barrier for Effective Treatment of Alzheimer’s Disease
Sanjay Arora, Buddhadev Layek, Jagdish Singh
Molecular Pharmaceutics (2020) Vol. 18, Iss. 2, pp. 714-725
Open Access | Times Cited: 105
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases
Maria Inês Teixeira, Carla M. Lopes, Maria Helena Amaral, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2020) Vol. 149, pp. 192-217
Closed Access | Times Cited: 97
Photodynamic cancer therapy using liposomes as an advanced vesicular photosensitizer delivery system
Saeid Moghassemi, Arezoo Dadashzadeh, Ricardo Bentes Azevedo, et al.
Journal of Controlled Release (2021) Vol. 339, pp. 75-90
Closed Access | Times Cited: 87
GLUT-1: An Effective Target To Deliver Brain-Derived Neurotrophic Factor Gene Across the Blood Brain Barrier
Sanjay Arora, Divya Sharma, Jagdish Singh
ACS Chemical Neuroscience (2020) Vol. 11, Iss. 11, pp. 1620-1633
Closed Access | Times Cited: 74
Biomaterials in treatment of Alzheimer's disease
Mukta Agrawal, Eluri Prathyusha, Hafiz Ahmed, et al.
Neurochemistry International (2021) Vol. 145, pp. 105008-105008
Closed Access | Times Cited: 59
Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges
Sofia Parrasia, Ildikò Szabó, Mario Zoratti, et al.
Molecular Pharmaceutics (2022) Vol. 19, Iss. 11, pp. 3700-3729
Open Access | Times Cited: 38
APOE effects on regional tau in preclinical Alzheimer’s disease
Christina B. Young, Emily Johns, Gabriel Kennedy, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 37
Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapy
Stéphanie Andrade, Maria do Carmo Pereira, Joana A. Loureiro
Colloids and Surfaces B Biointerfaces (2023) Vol. 225, pp. 113270-113270
Open Access | Times Cited: 34
Genetic Phenotypes of Alzheimer’s Disease: Mechanisms and Potential Therapy
Meina Quan, Shuman Cao, Qi Wang, et al.
Phenomics (2023) Vol. 3, Iss. 4, pp. 333-349
Open Access | Times Cited: 32
Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer’s disease
Nourhan M. Abdelmaksoud, Al-Aliaa M. Sallam, Ahmed I. Abulsoud, et al.
Pathology - Research and Practice (2023) Vol. 253, pp. 155007-155007
Closed Access | Times Cited: 23
Mechanistic insights and emerging therapeutic stratagems for Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Ageing Research Reviews (2024) Vol. 97, pp. 102309-102309
Closed Access | Times Cited: 14
Unexplored power of CRISPR-Cas9 in neuroscience, a multi-OMICs review
Mohammad Banazadeh, Ardavan Abiri, Mohammad Mahdi Poortaheri, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130413-130413
Closed Access | Times Cited: 8
Liposome based drug delivery as a potential treatment option for Alzheimer’s disease
Surabhi Shukla, Carely Hernandez
Neural Regeneration Research (2021) Vol. 17, Iss. 6, pp. 1190-1190
Open Access | Times Cited: 53
The Case against Antibiotics and for Anti-Virulence Therapeutics
Julia A. Hotinger, Seth T. Morris, Aaron E. May
Microorganisms (2021) Vol. 9, Iss. 10, pp. 2049-2049
Open Access | Times Cited: 41
From degenerative disease to malignant tumors: Insight to the function of ApoE
Ganggang Miao, Danping Zhuo, Xue Han, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114127-114127
Open Access | Times Cited: 31
Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression
Shaikh Sheeran Naser, Dibyangshee Singh, Subham Preetam, et al.
Materials Today Bio (2023) Vol. 21, pp. 100701-100701
Open Access | Times Cited: 18
Topical Ophthalmic Liposomes Dual-Modified with Penetratin and Hyaluronic Acid for the Noninvasive Treatment of Neovascular Age-Related Macular Degeneration
Chen Sun, Shuyue Zhang, Nan Xu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 1887-1908
Open Access | Times Cited: 6
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Dual-Modified Liposome for Targeted and Enhanced Gene Delivery into Mice Brain
Bruna dos Santos Rodrigues, Sushant Lakkadwala, Takahisa Kanekiyo, et al.
Journal of Pharmacology and Experimental Therapeutics (2020) Vol. 374, Iss. 3, pp. 354-365
Open Access | Times Cited: 46
<p>Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer’s Disease: A State-of-the-Art (2017–2020)</p>
Anna Binda, Carmen Murano, Ilaria Rivolta
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 6113-6135
Open Access | Times Cited: 41
In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy
Sanjay Arora, Jagdish Singh
International Journal of Pharmaceutics (2021) Vol. 608, pp. 121095-121095
Open Access | Times Cited: 33
Nanotechnology-based gene therapy as a credible tool in the treatment of Alzheimer’s disease
NigelH Greig, Aziz Unnisa, MohammadAmjad Kamal
Neural Regeneration Research (2023) Vol. 18, Iss. 10, pp. 2127-2127
Open Access | Times Cited: 15
ApoE-modified liposomes encapsulating resveratrol and salidroside alleviate manifestations of Alzheimer’s disease in APP/PS-1 mice
Mu-han Chen, Xin‐ze Liu, Xiuwu Qu, et al.
Drug Development and Industrial Pharmacy (2023) Vol. 49, Iss. 9, pp. 559-571
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top